340B Drug Pricing Program: Pharmacy Technician Guide

Understanding the 340B Drug Pricing Program

The 340B Drug Pricing Program is a federal program that requires drug manufacturers to provide outpatient drugs at significantly reduced prices to eligible healthcare organizations. Created by Section 340B of the Public Health Service Act in 1992, the program helps safety-net providers stretch scarce resources to reach more patients and provide more comprehensive services. Pharmacy technicians working in 340B-eligible facilities play important roles in maintaining program compliance.

How the 340B Program Works

The program operates through a straightforward mechanism. Drug manufacturers that participate in Medicaid must also offer discounted prices to covered entities registered in the 340B program. These discounts can range from 25% to 50% off the average manufacturer price, and for certain generic drugs, savings can be even greater. Covered entities purchase medications at the 340B discounted price and can then dispense them to eligible patients at regular rates, generating revenue that supports their mission of serving underserved populations.

The Health Resources and Services Administration (HRSA) oversees the 340B program. HRSA maintains the database of eligible covered entities, establishes program guidelines, and conducts audits to ensure compliance. Manufacturers are required to offer the 340B ceiling price to registered covered entities.

Covered Entities: Who Qualifies?

Not every healthcare facility can participate in the 340B program. HRSA designates specific types of organizations as eligible covered entities:

Hospitals

• Disproportionate share hospitals (DSH) that serve a high percentage of low-income patients
• Children's hospitals
• Cancer hospitals
• Critical access hospitals in rural areas
• Rural referral centers
• Sole community hospitals

Federal Grantees

• Federally Qualified Health Centers (FQHCs)
• Ryan White HIV/AIDS Program grantees
• STD clinics and TB clinics
• Family planning clinics (Title X)
• Hemophilia treatment centers
• Urban Indian health organizations
• Black Lung clinics

Each covered entity must register with HRSA's Office of Pharmacy Affairs and recertify annually. The entity must be enrolled in Medicaid and must not obtain 340B drugs through a group purchasing organization (GPO), with certain exceptions for specific entity types.

Patient Eligibility

340B drugs can only be dispensed to patients of the covered entity. Determining patient eligibility is one of the most complex aspects of 340B compliance. General requirements include:

• The patient must receive healthcare services from a provider employed by or under contract with the covered entity
• The covered entity must maintain records of the provider-patient relationship
• The patient must receive a prescription as a result of a healthcare encounter at the covered entity
• The prescriber must be listed on the covered entity's 340B database profile

A patient does not need to be uninsured or low-income to receive 340B-priced medications. Any patient who meets the relationship criteria with the covered entity is eligible, regardless of their insurance status or ability to pay.

Compliance Requirements and Prohibitions

340B program compliance revolves around two critical prohibitions established by law:

Duplicate Discount Prohibition

A covered entity cannot receive both a 340B discount and a Medicaid rebate on the same drug for the same patient. This would result in the manufacturer being charged twice for the same unit. Covered entities must have systems to identify Medicaid patients and ensure 340B-purchased drugs dispensed to them are excluded from Medicaid rebate claims, or that the drugs dispensed to Medicaid patients are purchased at non-340B prices.

Diversion Prohibition

340B drugs can only be dispensed to eligible patients of the covered entity. Transferring, selling, or dispensing 340B-priced drugs to ineligible individuals constitutes diversion and violates program requirements. Robust patient eligibility screening and inventory management systems are essential to prevent diversion.

Contract Pharmacy Arrangements

Many covered entities use contract pharmacy arrangements to provide 340B-priced medications to their patients. In these arrangements, the covered entity contracts with an outside pharmacy (often a retail chain) to dispense 340B drugs on its behalf. The contract pharmacy dispenses the medication, and the covered entity is responsible for ensuring compliance with all program rules.

Contract pharmacy arrangements have become increasingly complex and controversial. Manufacturers have imposed restrictions on contract pharmacy participation, and HRSA has issued guidance regarding these limitations. Pharmacy technicians working in contract pharmacy settings should understand their facility's specific 340B procedures.

The Pharmacy Technician's Role in 340B

Pharmacy technicians in 340B settings may be responsible for:

• Verifying patient eligibility through the pharmacy management system
• Correctly identifying 340B-eligible prescriptions during order processing
• Maintaining accurate inventory records separating 340B and non-340B stock
• Processing prescriptions through the appropriate purchasing account
• Supporting audit preparation by maintaining organized documentation
• Understanding the split billing or virtual inventory system used at the facility

PTCB Exam Relevance

For the PTCB exam, understand the basic purpose of the 340B program, know which types of facilities qualify as covered entities, and recognize the two key prohibitions (duplicate discounts and diversion). Questions may also address the role of HRSA in program oversight and the general concept of contract pharmacy arrangements. Familiarity with these fundamentals prepares you for both the exam and potential employment at 340B-eligible facilities.